Adaptive Biotechnologies Stock Quote ADPT - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

3.89

Bid

3.89

Ask

3.92

Volume

2,443,984

3.51 Day's Range 3.94

2.28 52 Week Range 8.51

Market Cap

515.789M

Previous Close

3.50

Open

3.65

Last Trade

3.9

Last Trade Time

Financial Volume

$ 9,265,069

VWAP

3.791

Average Volume (3m)

1,528,640

Shares Outstanding

147,368,324

Dividend Yield

PE Ratio

-2.54

Earnings Per Share (EPS)

-1.53

Revenue

170.28M

Net Profit

-225.25M

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.adaptivebiotech.com

Headquarters

Olympia, Washington, USA

Founded

1970

Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive Biotechnologies was $3.50. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of $ 2.28 to $ 8.51.

Adaptive Biotechnologies currently has 147,368,324 shares outstanding. The market capitalization of Adaptive Biotechnologies is $515.79 million. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -2.54.

Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024

SEATTLE, July 11, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

Form 8-K - Current report

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

SEATTLE, May 31, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.51	15.0887573964	3.38	3.94	3.33	948479	3.55617385	CS
4	0.44	12.7536231884	3.45	3.94	2.99	1442602	3.41337026	CS
12	1.44	58.7755102041	2.45	4.2	2.28	1528640	3.28601028	CS
26	-0.85	-17.9324894515	4.74	4.74	2.28	1579189	3.40292142	CS
52	-2.75	-41.4156626506	6.64	8.51	2.28	1491590	4.32254954	CS
156	-35.46	-90.1143583227	39.35	40	2.28	1205696	9.38047302	CS
260	-33.91	-89.708994709	37.8	71.25	2.28	1078326	19.4789898	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LCFYLocafy Ltd	$ 6.10 (162.92%)	46.08M
KZIAKazia Therapeutics Ltd	$ 1.24 (85.57%)	215.06M
CYNCYNGN Inc	$ 7.20 (81.82%)	17.89M
NEXINexImmune Inc	$ 3.84 (66.23%)	34.48M
BDRXBiodexa Pharmaceuticals PLC	$ 1.08 (51.88%)	59.99M
CETUUCetus Capital Acquisition Corporation	$ 7.00 (-29.72%)	1.42k
TRIBTrinity Biotech PLC	$ 2.046 (-28.96%)	81.97k
CINGCingulate Inc	$ 0.4845 (-25.23%)	1.38M
IVPInspire Veterinary Partners Inc	$ 5.5842 (-24.54%)	2.69M
SLRXSalarius Pharmaceuticals Inc	$ 2.12 (-22.70%)	2.03M
NVDANVIDIA Corporation	$ 127.40 (-5.57%)	374.79M
MAXNMaxeon Solar Technologies Ltd	$ 0.24 (13.85%)	355.51M
KZIAKazia Therapeutics Ltd	$ 1.24 (85.57%)	226.74M
TSLATesla Inc	$ 241.03 (-8.44%)	221.69M
SQQQProShares UltraPro Short QQQ	$ 7.63 (6.42%)	183.23M